Chugai receives Japanese approval for Lunsumio & Polivy combo therapy for additional indication of relapsed or refractory large B-cell lymphoma: Tokyo Tuesday, March 24, 2026, 11: ...
The FDA approves Wegovy HD (semaglutide 7.2 mg) for chronic weight management in adults with obesity or overweight and weight-related conditions.
Insights from the BSAC New Agents Conference focused on emergent fungal and viral disease threats and therapeutic innovations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results